Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with C5 polymorphism

Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with C5 polymorphism

US Patent 11052129 · Granted Jul 6, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EV576 for use in the treatment of viral infections of the respiratory tract2016
Method of treating myasthenia gravis2015